Pfizer Inc.
PFE
$23.49
$0.200.86%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/30/2025 | 12/31/2024 | 09/29/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 2.97B | 410.00M | 4.47B | 41.00M | 3.12B |
| Total Depreciation and Amortization | 1.61B | 1.79B | 1.75B | 1.73B | 1.73B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -327.00M | 1.60B | -377.00M | -14.00M | -421.00M |
| Change in Net Operating Assets | -1.92B | 2.93B | 879.00M | -3.54B | -3.34B |
| Cash from Operations | 2.34B | 6.72B | 6.71B | -1.78B | 1.09B |
| Capital Expenditure | -564.00M | -917.00M | -651.00M | -637.00M | -704.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.84B | -706.00M | -1.41B | 5.24B | 2.44B |
| Cash from Investing | 3.27B | -1.62B | -2.06B | 4.60B | 1.73B |
| Total Debt Issued | -- | 732.00M | 2.16B | 4.57B | 1.44B |
| Total Debt Repaid | -2.43B | -3.45B | -4.41B | -4.59B | -3.62B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.44B | -2.38B | -2.38B | -2.38B | -2.37B |
| Other Financing Activities | -356.00M | -14.00M | -6.00M | -63.00M | -386.00M |
| Cash from Financing | -5.23B | -5.11B | -4.64B | -2.46B | -4.93B |
| Foreign Exchange rate Adjustments | -7.00M | -29.00M | 9.00M | -18.00M | -28.00M |
| Miscellaneous Cash Flow Adjustments | -1.00M | -- | -1.00M | 1.00M | -- |
| Net Change in Cash | 374.00M | -45.00M | 29.00M | 343.00M | -2.14B |